{"id":"W1587476434","doi":"10.1002/cncr.29103","title":"Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; University of Ottawa; University of Manitoba; BC Cancer Agency; Interior Health; University of Alberta; Saint John Regional Hospital; Canadian Cancer Society; University of New Brunswick; Dalhousie University","funders":"Canadian Cancer Society; Alberta Cancer Foundation; Celgene","keywords":"Medicine; Lenalidomide; Internal medicine; Lymphoma; Refractory (planetary science); Clinical endpoint; Gastroenterology; Phases of clinical research; Surgery; Peripheral T-cell lymphoma; Mycosis fungoides; Toxicity; Clinical trial; Multiple myeloma; T cell; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004175016,0.001361661,0.001463383,0.0002324077,0.0005161052,0.0009579673,0.0007748238,0.001447957,0.003731464],"category_scores_gemma":[0.001707416,0.0004072715,0.0008490102,0.0001920769,0.0004233131,0.0004793335,0.0003645221,0.002645265,0.001120533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006372863,"about_ca_system_score_gemma":0.001924444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008730774,"about_ca_topic_score_gemma":0.001627429,"domain_scores_codex":[0.9991014,0.0004818465,0.0000728361,0.00009132315,0.0001312523,0.000121285],"domain_scores_gemma":[0.9987175,0.0002772525,0.000136731,0.00007660411,0.0002025088,0.0005894076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4955077,0.05858004,0.02366995,0.001880849,0.00600106,0.003551965,0.0007218168,0.003569351,0.07902882,0.0007796094,0.0749784,0.2517305],"study_design_scores_gemma":[0.5997148,0.3256863,0.02465221,0.0001498841,0.001196518,0.001318264,0.0000900081,0.001887577,0.008956173,0.0004185049,0.0358739,0.00005586481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9203998,0.009424771,0.005430759,0.007827154,0.001661436,0.0288099,0.01143583,0.0004003322,0.01461002],"genre_scores_gemma":[0.9244118,0.005389924,0.009794607,0.008530243,0.00124746,0.0181724,0.0201499,0.0000980003,0.0122057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004175016,"threshold_uncertainty_score":0.02207989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05764999082719615,"score_gpt":0.3921578100171123,"score_spread":0.3345078191899161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}